Literature DB >> 30913467

Sulfenamide derivatives can improve transporter-mediated cellular uptake of metformin and induce cytotoxicity in human breast adenocarcinoma cell lines.

Magdalena Markowicz-Piasecka1, Johanna Huttunen2, Joanna Sikora3, Kristiina M Huttunen4.   

Abstract

Metformin, the most frequently administered oral anti-diabetic drug, is a substrate for organic cation transporters (OCTs). This determines not only its pharmacokinetic properties but also its biochemical effects in humans, including its recently-discovered antiproliferative properties. The aim of the study was to verify the hypothesis whether chemical modification of its biguanide backbone may increase the cellular uptake and antiproliferative efficacy of metformin. The study examines five sulfenamide derivatives of metformin with differing lengths of alkyl chains. It determines their cellular uptake and the role of OCTs in their transport in human breast adenocarcinoma cells (epithelial-like MCF-7, and MDA-MB-231). It also evaluates whether increased cellular uptake of metformin derivatives is associated with their cytotoxic properties. Sulfenamide derivatives were characterized by a greater ability to bind to OCTs than metformin. Compound 2 with n-octyl alkyl chain was found to possess the greatest affinity towards OCTs, as measured by determination of [14C]choline uptake inhibition (IC50 = 236.1 ± 1.28 μmol/L, and 217.4 ± 1.33 μmol/L, for MCF-7 and MDA-MB-231 respectively). Sulfenamides were also found to exhibit better cellular uptake in comparison with the parent drug, metformin. For instance, the uptake of cyclohexyl derivative 1 was 1.28 ± 0.19 nmol/min/mg of proteins and thus was 12-fold higher than the metformin in MCF-7 cells. Furthermore, higher uptake was associated with the greatest antiproliferative properties expressed as the lowest IC50 value i.e. inhibiting the growth of 50% of the cells (IC50 = 0.72 ± 1.31 μmol/L). Collectively, chemical modification of metformin into sulfenamides with different alkyl substituents obtains better substrates for OCTs, and subsequently higher cellular uptake in MCF-7 and MDA-MB-231 cells. Additionally, the length of alkyl chain introduced to the sulfenamides was found to influence selectivity and transport efficiency via OCT1 compared to other possible transporters, as well as potential intracellular activity and cytotoxicity.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biguanides; Cellular uptake; Cytotoxicity; Metformin; Organic cation transporters (OCT)

Year:  2019        PMID: 30913467     DOI: 10.1016/j.bioorg.2019.03.036

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  4 in total

1.  Structural Comparison of Sulfonamide-Based Derivatives That Can Improve Anti-Coagulation Properties of Metformin.

Authors:  Agnieszka Zajda; Joanna Sikora; Kristiina M Huttunen; Magdalena Markowicz-Piasecka
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

2.  Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis.

Authors:  Magdalena Markowicz-Piasecka; Johanna Huttunen; Ahmed Montaser; Kristiina M Huttunen
Journal:  Apoptosis       Date:  2020-06       Impact factor: 4.677

3.  Incorporation of Sulfonamide Moiety into Biguanide Scaffold Results in Apoptosis Induction and Cell Cycle Arrest in MCF-7 Breast Cancer Cells.

Authors:  Magdalena Markowicz-Piasecka; Karol Sadowski; Johanna Huttunen; Joanna Sikora; Kristiina M Huttunen
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

4.  Effective Cellular Transport of Ortho-Halogenated Sulfonamide Derivatives of Metformin Is Related to Improved Antiproliferative Activity and Apoptosis Induction in MCF-7 Cells.

Authors:  Magdalena Markowicz-Piasecka; Ibrahim Komeil; Johanna Huttunen; Joanna Sikora; Kristiina M Huttunen
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.